Jeevan Scientific Technology Ltd 16 Nov 2026 12:00 AM
Jeevan Scientific Technology Ltd consolidated sales up 26.75% on year in Q2FY2027, net profit surged by 233.33%,
Jeevan Scientific Technology Ltd`s net profit jumped 233.33% to Rs 2.9 crore, while revenue from operations gained significantly 26.75% to Rs 23.17 crore in Q2FY27 over Q2FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 44010.55 crore, easing 8.93%. It has inched up 3.52% over last one week and crept higher by 3.42% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has gained 11.74% and 17.84% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 3.87 crore in Q2 FY27, surging by 12800.00% year-on-year, and jumping 294.90% quarter-on-quarter. EBITDA came in at Rs 5 crore, expanding by 181.82% YoY and rallying 89.57% sequentially. Total expenses advancing by 13.09% to Rs 19.26 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 1.55 crore, slightly declining by 9.36% YoY, while employee benefits expense was at Rs 6.68 crore, surging 16.38% YoY. For FY26, revenue from operations advanced 18.13% to Rs 46.84 crore, while net profit plunged by 104.51% to Rs 0.06 crore, compared to previous FY. EBITDA jumped by 327% to Rs 6.76 crore, and PBT tumbled by 103.13% to Rs 0.05 crore compared to previous FY. The company`s consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd soared by 46.66% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 3.42% during the same period.
Jeevan Scientific Technology Ltd 12 Nov 2026 12:00 AM
Jeevan Scientific Technology Ltd consolidated sales up 26.75% on year in Q2FY2027, net profit saw a strong growth of 233.33%,
Jeevan Scientific Technology Ltd share price jumped 9.78% to Rs 88.71 after the company`s net profit soared by 233.33% to Rs 2.9 crore, while revenue from operations gained significantly 26.75% to Rs 23.17 crore in Q2FY27 over Q2FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 43600.53 crore, easing 8.05%. It has improved by 3.10% over last one week and ticked higher by 1.47% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has edged up by 10.02% and 10.54% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 3.87 crore in Q2 FY27, expanding by 12800.00% year-on-year, and jumping 294.90% quarter-on-quarter. EBITDA came in at Rs 5 crore, rallying 181.82% YoY and surging by 89.57% sequentially. Total expenses increased by 13.09% to Rs 19.26 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 1.55 crore, softening by 9.36% YoY, while employee benefits expense was at Rs 6.68 crore, soaring 16.38% YoY. For FY26, revenue from operations advanced 18.13% to Rs 46.84 crore, while net profit witnessed a sharp fall of 104.51% to Rs 0.06 crore, compared to previous FY. EBITDA witnessed a strong improvement of 327% to Rs 6.76 crore, and PBT tumbled by 103.13% to Rs 0.05 crore compared to previous FY. The company`s consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd surged by 47.73% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.37% during the same period.
Jeevan Scientific Technology Ltd 11 Nov 2026 12:00 AM
Jeevan Scientific Technology Ltd consolidated sales up 26.75% on year in Q2FY2027, net profit surged by 233.33%,
Jeevan Scientific Technology Ltd share price softened by 1.57% to Rs 80.81. The Company`s net profit saw a strong growth of 233.33% to Rs 2.9 crore, while revenue from operations increased sharply by 26.75% to Rs 23.17 crore in Q2FY27 over Q2FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 43555.68 crore, gaining 8.05%. It has inched up 2.04% over last one week and ticked higher by 0.95% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has slipped by 1.09% and 3.02% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 3.87 crore in Q2 FY27, expanding by 12800.00% year-on-year, and jumping 294.90% quarter-on-quarter. EBITDA came in at Rs 5 crore, surging by 181.82% YoY and rallying 89.57% sequentially. Total expenses went up by 13.09% to Rs 19.26 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 1.55 crore, easing 9.36% YoY, while employee benefits expense was at Rs 6.68 crore, witnessing a strong rise of 16.38% YoY. For FY26, revenue from operations grew 18.13% to Rs 46.84 crore, while net profit witnessed a sharp fall of 104.51% to Rs 0.06 crore, compared to previous FY. EBITDA soared by 327% to Rs 6.76 crore, and PBT tanked by 103.13% to Rs 0.05 crore compared to previous FY. The company`s consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd rallied 34.68% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.91% during the same period.
Jeevan Scientific Technology Ltd 13 Aug 2026 12:00 AM
Jeevan Scientific Technology Ltd consolidated sales down 14.14% on year in Q2FY2026, net profit tumbled by 52.72%,
Jeevan Scientific Technology Ltd share price declined by 2.33% to Rs 78.52 after the company`s net profit witnessed a sharp fall of 52.72% to Rs 0.87 crore, while revenue from operations reduced 14.14% to Rs 18.28 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 39847.85 crore, retreating 13.17%. It has marginally improved by 2.14% over last one week and heading higher by 9.92% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has softened by 2.39% and 5.67% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 0.98 crore in Q2 FY26, plunging by 126.27% year-on-year, and crashing by 61.72% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 231.75% YoY and tanking 30.67% sequentially. Total expenses eased by 8.39% to Rs 17.03 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.71 crore, inching up 5.56% YoY, while employee benefits expense was at Rs 5.74 crore, slipping by 3.85% YoY. For the TTM ended FY26, revenue from operations improved 18.13% to Rs 46.84 crore, while net profit tanked by 104.51% to Rs 0.06 crore, compared to previous TTM. EBITDA soared by 327% to Rs 6.76 crore, and PBT collapsed by 103.13% to Rs 0.05 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd jumped 86.46% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.
Jeevan Scientific Technology Ltd 29 May 2026 12:00 AM
Jeevan Scientific Technology reports consolidated net profit of Rs 1.61 crore in the March 2026 quarter,
Net profit of Jeevan Scientific Technology reported to Rs 1.61 crore in the quarter ended March 2026 as against net loss of Rs 1.30 crore during the previous quarter ended March 2025. Sales rose 111.63% to Rs 21.29 crore in the quarter ended March 2026 as against Rs 10.06 crore during the previous quarter ended March 2025.For the full year,net profit rose 784.62% to Rs 1.15 crore in the year ended March 2026 as against Rs 0.13 crore during the previous year ended March 2025. Sales rose 31.38% to Rs 61.54 crore in the year ended March 2026 as against Rs 46.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales21.2910.06 112 61.5446.84 31 OPM %20.15-3.88 -15.9215.82 - PBDT4.17-0.78 LP 8.736.30 39 PBT2.56-2.55 LP 2.090.05 4080 NP1.61-1.30 LP 1.150.13 785 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now